India orders top drugmaker to halt eye medicine production at plant over quality lapses
CNA
The brief
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.
Reported by
CNA
This is a short headline brief. The complete report belongs to its publisher.
